Brave Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-261
| Closed | -$274K | – | 173 |
|
|
2024
Q3 | $274K | Hold |
261
| – | – | 0.07% | 109 |
|
|
2024
Q2 | $274K | Hold |
261
| – | – | 0.07% | 104 |
|
|
2024
Q1 | $251K | Hold |
261
| – | – | 0.07% | 111 |
|
|
2023
Q4 | $229K | Sell |
261
-50
| -16% | -$43.9K | 0.06% | 115 |
|
|
2023
Q3 | $256K | Hold |
311
| – | – | 0.08% | 101 |
|
|
2023
Q2 | $223K | Hold |
311
| – | – | 0.07% | 115 |
|
|
2023
Q1 | $256K | Hold |
311
| – | – | 0.08% | 100 |
|
|
2022
Q4 | $224K | Hold |
311
| – | – | 0.08% | 113 |
|
|
2022
Q3 | $214K | Buy |
+311
| New | +$214K | 0.11% | 107 |
|
|
2022
Q2 | – | Sell |
-311
| Closed | -$217K | – | 158 |
|
|
2022
Q1 | $217K | Buy |
+311
| New | +$217K | 0.07% | 130 |
|
|
2016
Q4 | – | Sell |
-420
| Closed | -$169K | – | 282 |
|
|
2016
Q3 | $169K | Sell |
420
-30
| -7% | -$12.1K | 0.11% | 136 |
|
|
2016
Q2 | $157K | Buy |
+450
| New | +$157K | 0.11% | 144 |
|